REBECA DEL RIO ARCE: Open Payments
NPI 1669771531 · KISSIMMEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 31 payments from 13 companies in 2025. Trend: 2023 $444 · 2024 $1,351 · 2025 $829
Food & beverage: $731Education: $98
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 6 | $163 |
| Otsuka America Pharmaceutical, Inc. | 5 | $145 |
| OPKO Pharmaceuticals, LLC | 4 | $98 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $92 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $68 |
| Calliditas Therapeutics US Inc. | 3 | $56 |
| MERZ NORTH AMERICA, INC. | 1 | $41 |
| Amgen Inc. | 1 | $37 |
| Apellis Pharmaceuticals, Inc. | 1 | $31 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $30 |
Products named: Fabhalta, JYNARQUE, RAYALDEE, Kerendia, JARDIANCE, TARPEYO, Xeomin, KRYSTEXXA.
Industry payments across FL — which companies pay providers there.
